万氏清心化痰汤对脑小血管病大鼠神经血管单元及AMPK/SIRT1/PGC1α通路的影响OA
Wan's Qingxin Huatan Decoction Attenuates Cerebral Small Vessel Disease in Rats by Modulating the Neurovascular Unit and the AMPK/SIRT1/PGC1α Pathway
[目的]探讨万氏清心化痰汤对脑小血管病大鼠的治疗作用及机制.[方法]采用高脂喂饲结合改良2-血管阻断法构建脑小血管病模型.将造模成功的脑小血管病大鼠随机分为模型组,万氏清心化痰汤低、中、高剂量组及尼莫地平组,另设假手术组,每组12只.分组干预后,采用Morris水迷宫试验[逃避潜伏期、穿越平台次数,目标象限停留时间]评估大鼠认知功能,苏木精-伊红(HE)染色法观察海马组织病理形态,尼氏染色法观察海马神经元尼氏体形态、数量和分布,高尔基染色法观察海马组织神经元树突变化,Western Blot法检测脑组织神经血管单元[胶质纤维酸性蛋白(GFAP)、水通道蛋白4(AQP-4)、神经核抗原(NeuN)、微管相关蛋白2(MAP-2)]及腺苷酸激活蛋白激酶(AMPK)/沉默调节蛋白1(SIRT1)/过氧化物酶体增殖活化受体γ辅助活化因子1α(PGC1α)通路相关蛋白表达水平.[结果]与假手术组比较,模型组大鼠海马区神经元排列稀疏,形态不规则,尼氏小体数量减少,逃避潜伏期及脑组织GFAP、AQP-4蛋白相对表达量增加(P<0.05),穿越平台次数、目标象限停留时间,神经元树突全长、树突棘密度及脑组织NeuN、MAP-2、磷酸化(p)-AMPK/AMPK、SIRT1、PGC1α蛋白相对表达量降低(P<0.05);与模型组比较,万氏清心化痰汤低、中、高剂量组和尼莫地平组大鼠神经元排列较齐,形态结构改善,尼氏小体数量增加,逃避潜伏期及脑组织GFAP、AQP-4蛋白相对表达量减少(P<0.05),穿越平台次数,目标象限停留时间,神经元树突全长、树突棘密度及脑组织NeuN、MAP-2、p-AMPK/AMPK、SIRT1、PGC1α蛋白相对表达量增加(P<0.05).万氏清心化痰汤高剂量组上述各指标与尼莫地平组比较,差异均无统计学意义(P>0.05).[结论]万氏清心化痰汤能够激活AMPK/SIRT1/PGC1α通路,修复神经血管单元,保护脑小血管病大鼠脑功能和结构,改善认知障碍.
Objective To investigate the therapeutic effect and mechanism of Wan's Qingxin Huatan Decoction in rats with cerebral small vessel disease(CSVD).Methods The CSVD model was established by a high-fat diet combined with a modified two-vessel occlusion(2-VO)method.Successfully modeled rats were randomly divided into a model group,low-,medium-,and high-dose Wan's Qingxin Huatan Decoction groups,and a nimodipine group,with a sham operation group also established(n=12 per group).After the respective interventions,cognitive function was assessed using the Morris water maze test(escape latency,number of platform crossings,and time spent in the target quadrant).Histopathological changes in the hippocampus were observed by hematoxylin-eosin(HE)staining.Nissl staining was used to evaluate the morphology,number,and distribution of Nissl bodies in hippocampal neurons.Golgi staining was performed to observe dendrites changes in hippocampal neurons.Western Blot analysis was conducted to detect the expression of neurovascular unit-related proteins[glial fibrillary acidic protein(GFAP),aquaporin-4(AQP-4),neuronal nuclei antigen(NeuN),and microtubule-associated protein 2(MAP-2)],as well as proteins involved in the AMP-activated protein kinase(AMPK)/sirtuin 1(SIRT1)/peroxisome proliferator-activated receptor gamma coactivator 1-alpha(PGC1α)pathway.Results Compared with the sham operation group,the model group exhibited sparsely arranged and irregularly shaped neurons in the hippocampus,a reduced number of Nissl bodies,prolonged escape latency,and increased relative protein expression of GFAP and AQP-4 in brain tissue(P<0.05),while the number of platform crossings,time spent in the target quadrant,total dendritic length,dendritic spine density,and relative protein expression of NeuN,MAP-2,p-AMPK/AMPK,SIRT1,and PGC1α were significantly decreased(P<0.05).Compared with the model group,the low-,medium-,and high-dose Wan's Qingxin Huatan Decoction groups and the nimodipine group showed more regularly arranged neurons,improved morphological structure,an increased number of Nissl bodies,shortened escape latency,and decreased relative protein expression of GFAP and AQP-4,along with increases in the number of platform crossings,time spent in the target quadrant,total dendritic length,dendritic spine density,and the relative protein expression of NeuN,MAP-2,p-AMPK/AMPK,SIRT1,and PGC1α(P<0.05).No statistically significant differences were observed in any of these indicators between the high-dose Wan's Qingxin Huatan Decoction group and the nimodipine group(P>0.05).Conclusion Wan's Qingxin Huatan Decoction can activate the AMPK/SIRT1/PGC1α pathway,repair the neurovascular unit,protect brain function and structure,and ameliorate cognitive impairment in rats with CSVD.
刘麒麟;姜磊;靳晶;张雯;杨畅;赵文静;罗艺璇
武汉市中医医院脑病科,湖北 武汉 430000武汉市中医医院脑病科,湖北 武汉 430000武汉市中医医院脑病科,湖北 武汉 430000武汉市中医医院脑病科,湖北 武汉 430000武汉市中医医院脑病科,湖北 武汉 430000武汉市中医医院脑病科,湖北 武汉 430000武汉市中医医院脑病科,湖北 武汉 430000
医药卫生
万氏清心化痰汤脑小血管病神经血管单元AMPK/SIRT1/PGC1α通路大鼠
Wan's Qingxin Huatan Decoctioncerebral small vessel disease(CSVD)neurovascular unitAMPK/SIRT1/PGC1α pathwayrats
《广州中医药大学学报》 2026 (8)
2202-2209,8
湖北省时珍人才工程科研项目(鄂卫函[2024]256号)武汉市中医药科研项目(编号:WZ24B42)
评论